| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,948,284 |
|
|
Indirect Shares
|
60,990,264 |
|
|
| Direct
Value |
$199,176,147 |
|
|
|
Indirect Value
|
$173,068,344 |
|
|
| Total
Shares |
88,938,548 |
|
|
| Total
Value |
$372,244,491 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
95
|
|
Stock
price went up :
|
14
|
1
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,834.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-19 |
1,566,956 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-01-23 |
7,594 |
2024-01-23 |
6,955,191 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2023-08-23 |
30,707,722 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
630 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIOL |
Biolase Inc |
|
– – – |
2014-11-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,604,166 |
|
- |
|
| AWH |
Aspira Womens Health Inc |
|
• • • |
2017-02-13 |
4 |
B |
$1.40 |
$1,363,713 |
I/I |
974,081 |
3,132,220 |
2.64 |
- |
|
| AWH |
Aspira Womens Health Inc |
|
• • • |
2017-08-31 |
4 |
OE |
$1.00 |
$773,003 |
I/I |
773,003 |
3,905,223 |
0 |
- |
|
| AWH |
Aspira Womens Health Inc |
|
• • • |
2018-04-17 |
4 |
B |
$1.00 |
$2,838,090 |
I/I |
2,838,090 |
13,416,342 |
0.01 |
- |
|
| AWH |
Aspira Womens Health Inc |
|
• • • |
2018-06-21 |
4 |
OE |
$1.00 |
$3,961,900 |
I/I |
3,961,900 |
17,378,242 |
0 |
- |
|
| AWH |
Aspira Womens Health Inc |
|
• • • |
2019-06-28 |
4 |
B |
$0.80 |
$4,000,000 |
I/I |
5,000,000 |
22,378,242 |
0.01 |
- |
|
| BIOL |
Biolase Inc |
|
• • • |
2020-02-11 |
4 |
S |
$0.60 |
$784,759 |
I/I |
(1,307,931) |
739,820 |
0 |
% |
|
| AWH |
Aspira Womens Health Inc |
|
• • • |
2020-06-09 |
4 |
OE |
$1.80 |
$1,315,008 |
I/I |
730,560 |
23,108,802 |
0 |
- |
|
| AWH |
Aspira Womens Health Inc |
|
• • • |
2020-07-01 |
4 |
B |
$3.50 |
$8,000,003 |
I/I |
2,285,715 |
25,394,517 |
0.01 |
- |
|
| BDSX |
Biodesix Inc |
|
• • • |
2020-12-07 |
4 |
OE |
$6.83 |
$400,218 |
I/I |
58,597 |
5,725,419 |
0 |
- |
|
| AWH |
Aspira Womens Health Inc |
|
• • • |
2022-08-25 |
4 |
B |
$0.00 |
$0 |
I/I |
133,333 |
25,527,850 |
0.01 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-06 |
4 |
S |
$2.96 |
$14,507 |
I/I |
(4,901) |
856,115 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-07 |
4 |
S |
$2.90 |
$580 |
I/I |
(200) |
855,915 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-11 |
4 |
S |
$2.96 |
$2,664 |
I/I |
(900) |
855,015 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-12 |
4 |
S |
$2.85 |
$3,420 |
I/I |
(1,200) |
853,815 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-13 |
4 |
S |
$2.88 |
$8,640 |
I/I |
(3,000) |
850,815 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
|
• • • |
2022-10-13 |
4 |
S |
$1.52 |
$608 |
I/I |
(400) |
466,266 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-14 |
4 |
S |
$3.20 |
$9,600 |
I/I |
(3,000) |
847,815 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-17 |
4 |
S |
$3.34 |
$84,646 |
I/I |
(25,343) |
822,472 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-18 |
4 |
S |
$3.35 |
$46,304 |
I/I |
(13,822) |
808,650 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-19 |
4 |
S |
$3.22 |
$13,714 |
I/I |
(4,259) |
804,391 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-20 |
4 |
S |
$3.14 |
$13,188 |
I/I |
(4,200) |
800,191 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-21 |
4 |
S |
$3.09 |
$62,844 |
I/I |
(20,338) |
779,853 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-24 |
4 |
S |
$3.06 |
$14,153 |
I/I |
(4,625) |
775,228 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-25 |
4 |
S |
$3.07 |
$9,643 |
I/I |
(3,141) |
772,087 |
0 |
% |
|
630 Records found
|
|
Page 1 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
